Forecast & Rating3 analysts currently cover Cadrenal Therapeutics, of which 2 give a positive rating. The average price target is $14.00, about 993.8% upside from the current price of $1.28. Coverage is limited, so the data is for reference only. Data as of Sep 1, 2026; this does not constitute investment advice.
Sep 1, 2026Price forecast
$14.00993.75%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 31, 2026
Forecast met0.0%
Stock price$1.28
Avg. target$35.7
High target$45
Low target$30
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.